Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1994 Jun 21;91(13):6002-6.
doi: 10.1073/pnas.91.13.6002.

Loss of receptors for transforming growth factor beta in human T-cell malignancies

Affiliations
Case Reports

Loss of receptors for transforming growth factor beta in human T-cell malignancies

M E Kadin et al. Proc Natl Acad Sci U S A. .

Abstract

Ki-1 (CD30)+ cutaneous T-cell lymphomas CTCLs) are slowly progressive lymphomas in which initial spontaneous regression is often observed. To better understand the mechanisms of spontaneous regression and eventual tumor progression in Ki-1+ CTCLs, type beta transforming growth factor (TGF-beta)-mediated growth inhibition of clonally related cell lines derived from two time points, before and after tumor progression, was studied. TGF-beta 1 inhibited colony-forming efficiency (CFE) of a cell line (Mac-1) derived from clinically indolent Ki-1+ CTCLs but failed to inhibit CFE of Mac-2A and -2B cell lines from advanced CTCLs. To determine the basis for TGF-beta 1 resistance in advanced CTCL cells, we looked for possible defects in the expression of cell surface TGF-beta receptors. Mac-1 cells were found to express TGF-beta receptors I and II, which mediate growth inhibition, and the TGF-beta-binding proteoglycan betaglycan. In contrast, receptors I and II were not detected in CTCL lines Mac-2A and -2B even though these cell lines did express betaglycan. Various treatments that unmask or induce TGF-beta receptors in other cells failed to show evidence for these receptors in advanced CTCL cells. Loss of TGF-beta receptor expression in these cells correlated with a marked decrease in TGF-beta receptor II mRNA levels. Loss of cell surface TGF-beta receptors was also found in two of five other patients with T-cell lymphomas including the Sezary syndrome and a noncutaneous T-cell lymphoma, suggesting that loss of TGF-beta receptor expression may be a recurrent feature of human T-cell malignancies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Dermatol. 1968 Jan;97(1):23-30 - PubMed
    1. J Biol Chem. 1990 Nov 25;265(33):20533-8 - PubMed
    1. Annu Rev Cell Biol. 1990;6:597-641 - PubMed
    1. Cell Growth Differ. 1990 Nov;1(11):549-57 - PubMed
    1. J Biol Chem. 1991 May 25;266(15):9617-21 - PubMed

Publication types

MeSH terms

Substances